News for Lannett Company, Inc. (LCI)

/PRNewswire/ -- The "Phenobarbital Market, By Indication, By Dosage Form, By Distribution Channel, and By Geography- Size, Share, Outlook, and Opportunity...

/PRNewswire/ -- The

The Global Gout Therapeutics Market Size was valued at USD 2.1 Billion in 2022 and the worldwide gout therapeutics market Size is expected to reach USD 7.1...

Restructuring Support Agreement Supported by Holders of More than 80% of the Company's Senior Secured Notes and 100% of Holders of Second Lien Term Loan Restructuring Transactions Will Reduce the... | May 3, 2023

/PRNewswire/ -- Lannett Company, Inc. (OTCMKTS: LCIN) (the "Company" or "Lannett") today announced that it and certain of its subsidiaries have commenced...

NYSE to Immediately Suspend Trading in Lannett , Commences Delisting

/PRNewswire/ -- Lannett Company, Inc. (LCI) ("Lannett" or "the Company") today announced that it received a written notice from the New York Stock Exchange...

AMRX | Complete Amneal Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

/PRNewswire/ -- The "Active Pharmaceutical Ingredients (API) Global Market - Forecast To 2029" & "Pharmaceutical Excipients Global Market - Forecast To 2029"...

The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.05 A.M. ET)..

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly traded company.

Read Analysts’ New Coverage for May 24th (AAMC, AAU, ACU, ADXS, ALDX, APLD, AUMN, AZN, CFTLF, CRBP) at ETF Daily News

PARAMUS, N.J., March 23, 2022 (GLOBE NEWSWIRE) -- Epygenix Therapeutics, a clinical-stage biopharmaceutical company developing drugs for rare and...

Although the Central Bank of Russia boosted its benchmark policy rate by 100bps to 9.5% during its recent meeting, there were a few notable insider trades.

Financial executive with strong public company experience joins growing Avisa team SANTA FE, N.M., June 22, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics